Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Clinical Trial

Seniors Taking Antidepressants May Benefit from Adding a Daily Probiotic, New Clinical Trial Finds

A June 2026 clinical trial found seniors with depression who added a daily probiotic to antidepressants improved more than those on placebo. Here's what the research actually shows.

Medical Daily

US releases experimental Ebola drug for DR Congo outbreak trials

Experimental Ebola drugs are being shipped to Democratic Republic of Congo as the United States releases doses of a treatment for clinical trials in a widening outbreak that has caused more than 1,000 cases and over 250 deaths, the World Health Organization and US officials have said.

Radio France Internationale

Daily Pill Cuts Sleep Apnea Breathing Pauses by 47% in Lancet Clinical Trial, Offering Hope for Alternative Treatment

A Lancet clinical trial of 298 adults with moderate-to-severe sleep apnea found sulthiame reduced breathing interruptions by up to 47% with improved oxygen levels overnight.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

University of Florida Study Warns Glucosamine Users After Finding Link to 25% Faster Alzheimer's Disease Progression

University of Florida study in Nature Metabolism, June 9, 2026: glucosamine use linked to 25% faster MCI-to-Alzheimer's progression. What elderly supplement users need to know.

Medical Daily

Clinical Trial: Adding a Daily Probiotic to Antidepressant Treatment Reduced Depression and Anxiety in Older Adults

JAGS clinical trial June 17, 2026: 58 older adults adding daily probiotics to antidepressants showed meaningful depression and anxiety reductions vs. placebo over 12 weeks.

Medical Daily

Could a Simple Blood Test Stop Lung Cancer Early?

What if a simple blood test could tell you that lung cancer might develop years before it actually appears? It sounds like science fiction, but researchers believe it could soon become reality. A groundbreaking study has identified a unique set of proteins in the blood that may reveal a person's…

MyLifeXP

Novo Nordisk reveals cyberattack: Ozempic and Wegovy maker says clinical trials data breached

The company says the data is pseudonymous and apparently can't be linked to actual people.

TechRadar

Read news from The Economist, FT, and more,
with one subscription

Autistic children being injected with unapproved stem cell treatments supported by RFK Jr

Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus

The Guardian - US

ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens

JENA, Germany, June 11, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today the successful early clinical implantations of the ZEISS AT LUCIA toric 721P intraocular lens (IOL), designed to treat cataracts while simultaneously correcting astigmatism. ZEISS is currently conducting an early-access clinical trial with a select group of highly experienced…

AAP

Chicago's VA Hospital Just Enrolled Its First Veterans in a Psilocybin-Assisted Therapy Program — And the Science Behind Their PTSD Treatment Is Changing Psychiatry

A new VA clinical trial in Chicago is testing psilocybin-assisted therapy for treatment-resistant PTSD, offering hope to veterans.

Medical Daily

Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip race

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after completing clinical trials. Developed by Tsinghua University and Neuracle Technology, the less invasive implant aims to aid individuals with paralysis and spinal cord injuries, marking a significant milestone ahead of Elon…

The Economic Times

Probiotic firm hopes for great things from new strain

A clinical trial is underway at La Trobe University and its Athens counterpart for an Australian-made probiotic, its owners hope will be used for inflammation.

AAP

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10

SHENZHEN, China, June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently developed by Shenzhen Kexing Pharmaceutical Co., Ltd. ("Shenzhen Kexing"), a wholly-owned subsidiary of Kexing Biopharm. Designed to treat neovascular…

AAP

Scientists raise alarm about effects of commonly prescribed sleeping pill

Low-dose quetiapine improves sleep quality but significantly impairs next-day alertness and driving performance, new clinical trial finds

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak in Africa. The vaccine uses technology similar to the Oxford-AstraZeneca Covid-19 vaccine. This partnership aims to accelerate development and ensure access…

The Guardian - UK

Yoga can reduce anxiety and insomnia for people living with cancer, study finds

First clinical trial of its kind, involving 410 cancer survivors in US, also finds reductions in distress and fatigue

The Independent UK

New cancer jab returns ‘unprecedented’ results in major clinical trial

IN FULL

The Conversation

How a remarkable trial on bedrest during the Korean war helped lead to evidence-based medicine

In 1959, a young doctor named David Sackett stumbled on a clinical trial that would change his life – and most of ours. The study showed that conventional wisdom on bed rest in medicine was wrong. And it helped lead Sackett and others to develop evidence-based medicine, in which doctors…

Get all your
news in one place.

100's of premium titles.
One news app.

Budget and the Bees

GLP-1 Drugs Could Soon Treat Heart Failure and Peripheral Artery Disease—FDA Approvals Coming

GLP-1 drugs are no longer just weight-loss and diabetes medications. Researchers are now studying whether these blockbuster treatments can help people living with heart failure and peripheral artery disease (PAD), two serious conditions affecting millions of Americans. That shift could reshape how doctors manage cardiovascular disease in the coming years.…

AAP

Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

CARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today announced the initiation of a Phase I, first-in-human clinical trial evaluating gemcitabine delivered via its iontophoretic oncology platform (IOP) for the treatment of pancreatic cancer. The study,…

Budget and the Bees

Can’t Stand Your CPAP? New Pill Slashes Sleep Apnea Events by 47% in Clinical Trials — When Could It Reach Patients?

Millions of people with obstructive sleep apnea know the nightly struggle of wearing a CPAP mask. While continuous positive airway pressure remains the gold standard treatment, many patients stop using it because of discomfort, dry mouth, noise, or claustrophobia. Now, a new sleep apnea pill called sulthiame is drawing attention…

AAP

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients…

Budget and the Bees

A 4-Week Diabetes Miracle? All 10 Patients in a Chicago Trial Achieved Insulin Independence — Could This Cure Be Coming Soon

For millions of Americans living with Type 1 diabetes, every day revolves around insulin shots, glucose monitors, meal planning, and the constant fear of dangerous blood sugar swings. That is why a small but groundbreaking clinical trial in Chicago is creating massive buzz in the medical world. Researchers reported that…

MarketBeat

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m

The Conversation

Clinical trials that are actually marketing ploys targeting doctors – how seeding trials put profit over patients

Some clinical trials aren’t designed to answer scientific questions. They’re designed to market drugs. In our recently published research, my team and I analyzed over 34,000 industry-funded trials and found that hundreds of studies across seven medical fields were likely designed to promote a drug to physicians rather than to…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

University of Florida

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.